Table 5.
Combined model | Univariate analysis | Multivariate analysis | ||
---|---|---|---|---|
Factors | P | Hazard ratio | P | Hazard ratio |
Tumor diameter | <.05a | 1.26 (1.09-1.46) | ||
Clinical TNM stage | .01a | 1.85 (1.12-3.07) | ||
Lymph node metastasis | .01a | 1.26 (1.04-1.53) | ||
Distant metastasis | .01a | 2.09 (1.17-3.71) | ||
GleasonSum | <.05a | 1.30 (1.13-1.50) | .04a | 1.24 (1.01-1.54) |
Preoperative PSA | .02a | 1.05 (1.01-1.10) | .04a | 1.07 (1.00-1.14) |
PI | .03a | 1.05 (1.00-1.10) | ||
AT | <.05a | 1.07 (1.02-1.13) | .03a | 1.09 (1.01-1.19) |
elastography grade | .04a | 1.19 (1.01-1.41) | ||
Radscore1 | <.05a | 3.43 (1.91-6.16) | <.05a | 5.28 (1.85-9.89) |
Radscore2 | <.05a | 2.63 (1.93-3.58) | <.05a | 2.60 (1.81-3.73) |
Abbreviations: CEUS, contrast-enhanced ultrasound; BCR, biochemical recurrence; PI, peak intensity; AT, arrival time; MRI, magnetic resonance imaging; TNM, tumor node metastasis classification.
P < .05.